Clinical Trial Update: MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial [Phase 2]

View source ↗

Summary

The Phase 2 MIST trial evaluating metabolic intervention with semaglutide and THR-β therapy for adult obesity is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• THR-β therapy
• semaglutide (semaglutide)

Snippet

Sponsor: Eccogene | Conditions: Adult Obesity, Weight Management | Phase 2 | Status: NOT_YET_RECRUITING